Oneal comprehensive cancer center

The MajesTEC-3 clinical trial shows that using a new two-drug immunotherapy regimen can lead to long-lasting remission for patients with multiple myeloma. Over 83 percent of patients enrolled in the trial are alive and progression-free three years after therapy.

Heidi Neas was diagnosed with cancer at 16 weeks pregnant, became cancer-free at 22 weeks and delivered a healthy baby boy.

UAB experts, medical students and undergraduate students are dedicated to raising awareness of cervical cancer and promoting information on prevention, diagnosis and treatment.

The proceeds from the gala will be put toward O’Neal Invests — a fund focused on high-priority research efforts.

Technology and treatment planning have made shorter-course radiation a safe, effective and patient-centered option for breast cancer care.

A UAB urologist has been selected as a recipient of the highly competitive 2025 National Cancer Institute Early Career Cancer Clinical Investigator Award.

At just 43 years old, Latrivia Carter was diagnosed with stage 2 triple-negative breast cancer.

UAB physicians say this type of cancer treatment is often associated with higher cure rates, longer life spans, better outcomes and fewer side effects.

Screenings are important in the standardized health care of middle-aged men.

Tumor therapy with immune checkpoint blockers may be improved by fine-tuning Gfi1 in CD8+ T cells.

UAB researchers have identified a critical vulnerability in quadruple-negative breast cancer, signaling pathway as a key driver of tumor growth and paving the way for targeted therapies that spare healthy cells.

There are several ways one can increase their health and reduce the strain put on their pancreas through diet and wellness modifications.

Regional Wellness Day will take place 3-7 p.m. at the Birmingham CrossPlex located at 2340 Crossplex Blvd. Birmingham, AL 35208. To register, click here.

UAB is ranked No. 164 based on exceptional academic research portfolio and its overall global and regional reputation.

The regulator HIF1α functions in a cancer-microenvironment that lacks oxygen, and it may be involved in resistance to immune checkpoint blockade therapy.

Grants from the Breast Cancer Research Foundation of Alabama will support 10 groundbreaking projects led by researchers at UAB. 

The goal of this project is to reduce health disparities in colonoscopy screening and colorectal cancer outcomes for vulnerable populations in Jefferson County.

Join the UAB “Stubble To Support Men’s Health” campaign and make a difference in the fight against prostate cancer by growing facial hair in support of the cause.

This polygenic score predicts tamoxifen treatment resistance is better than conventional methods, with potential for personalized medicine application.

The BC – NiCE study was developed to promote breast and cervical screening in the state of Alabama for Black women.